EP #1178: Demystifying the Self-Care Aspect of Psychedelics: A Beginner's Look at Their Therapeutic Use

Send us a text Lisa is joined by Matt Zemon, the author of Psychedelics for Everyone: A Beginner’s Guide to These Powerful Medicines for Anxiety, Depression, Addiction, PTSD, and Expanding Consciousness . Since 2019, Matt has evolved from someone who had never taken any drugs to doing a deep dive into the study of human consciousness with the help of psilocybin, ayahuasca, ketamine, LSD, MDMA, DMT, 5-MeO-DMT, and more. He is now CEO and Co-Founder of HAPPŸŸ , a mental wellness company, specializing in psychedelic-assisted oral ketamine therapy along with digital therapeutics that promote transforming outcomes. Previously, Matt was the co-founder and Chief Strategy Officer of Psychable, an online community connecting people interested in the healing power of psychedelics with a network of practitioners and psychedelic-based treatments, and also the co-founder of Take2Minutes, a nonprofit dedicated to helping individuals improve their mental health and wellbeing. He lives in Chapel Hill, NC. For more information: https://www.MattZemon.com After more than five decades of prohibition, the attitudes and laws around psychedelics are starting to shift as more people are beginning to see the benefits that they offer. In addition, recent studies show that there is new hope in the treatment of depression and anxiety that is more effective than antidepressants. Scientists are finding increasing evidence for the benefits of mind-altering drugs such as ketamine, MDMA, and psilocybin mushrooms. In fact, brain-imaging studies have found that these psychedelic drugs help increase connectivity in the brain. “This is not just hippy-talk,” Matt Zemon, MSc, says. “We are seeing that major universities, government scientists, and big pharma are studying psychedelic drugs for mental health – with almost 100 clinical studies happening right now and more than 300 university psychedelic programs in place." After years of suffering from depression, Matt Zemon, MSc, experienced a guided psilocybin (magic mushroom) journey, and it completely changed his worldview. So transformational, he enrolled in a Master’s of Science in Psychology and Neuroscience of Mental Health from King’s College, London (which boasts cutting edge psychedelic research) and graduated with honors. He is now CEO and Co-Founder of HAPPŸY, a mental wellness company, specializing in psychedelic-assisted oral ketamine therapy along with digital therapeutics that promote transforming outcomes. Thank you to our sponsor for this episode Just Thrive Probiotics. you can get 15% off sitewide at justthrivehealth.com with promo code: Natsav15. To learn more about this groundbreaking company, don’t miss episode #1174 where I chatted with Tina, the CEO, and co-founder.